- Home
- / Caplin Point Laboratories
Caplin Point Laboratories
Stock Price
₹1.9 K
2024-10-29
Market Capitalization
₹145.8 B
2024-10-29
Revenue
₹19.2 B
FY, 2025
Caplin Point Laboratories Summary
Company Summary
- Overview
- Caplin Point Laboratories is a pharmaceutical company manufacturing a range of formulations. It offers tablets, capsules, granules, liquid orals, ointments, and creams.
- Type
- Public
- Status
- Active
- Founded
- 1990
- HQ
- Chennai, IN | view all locations
- Website
- http://www.caplinpoint.net/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
D Sathyanarayanan, Director
LocationsView all
5 locations detected
Chennai, TN HQ
India
3, Industrial Estate, Perungudi
Chennai, TN
India
3, Lakshmanan St, Parthasarathi Puram, T. Nagar
Gerugambakkam, TN
India
Suthukeny
India
HP
India
Caplin Point Laboratories Financials
Summary Financials
- Revenue (Q3, 2026)
- ₹5.4B
- Gross profit (Q3, 2026)
- ₹3.6B
- Net income (Q3, 2026)
- ₹1.7B
- Cash (FY, 2026)
- ₹6.2B
- EBIT (Q3, 2026)
- ₹2.0B
- Enterprise value
- $139.7B